Cover Image
市場調查報告書

中國的經腸營養劑市場分析與投資預測評估 (2015∼2020年)

Research and Investment Forecast Evaluation of China's Enteral Nutrition Preparation Market from 2015 to 2020

出版商 Huidian Research 商品編碼 326436
出版日期 內容資訊 英文 59 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的經腸營養劑市場分析與投資預測評估 (2015∼2020年) Research and Investment Forecast Evaluation of China's Enteral Nutrition Preparation Market from 2015 to 2020
出版日期: 2015年03月20日 內容資訊: 英文 59 Pages
簡介

中國的經腸營養市場從1960∼70年代開始,不過,這10年產品進行開發,市場急速成長、多樣化了。還有經腸營養劑在中國市場完全紮根,結果國內企業相繼進入,2010年為221億人民幣的市場規模,到2014年終擴大到411億人民幣。但,中國的經腸營養劑產業至今仍處於初期階段,中國產品在品質、種類數方面大幅落後國外,高品質產品由外資型企業和合資企業獨佔的狀態。今後,依據新的研究開發活動的結果,產品的開發、改良,及安全性、便利性的強化,尤其是「一體型 (all-in-one)」產品,及非口服式營養攝取方法的開發等將變得重要。

本報告提供中國的經腸營養劑市場最新趨勢與未來展望相關分析、全全球和中國的市場結構和競爭結構、到目前為止的生產、銷售、價格、技術開發的轉變、今後的市場趨勢和發展的方向性、主要企業簡介(業績、市場佔有率、開發策略)、今後的投資機會與風險等估計、考察。

第1章 中國的經腸營養劑產品概要

第2章 海外市場上的經腸營養劑

  • 摘要
  • 亞洲市場概要
  • 歐洲市場
  • 美國市場

第3章 經腸營養劑環境分析

  • 中國的經濟開發環境
    • GDP成長率的變動
    • 固定投資成長率的變動
    • 進出口額增加率的變動
    • 宏觀經濟的發展預測
  • 相關產業政策、法規、規定、標準
    • 中國的相關法規
    • 在其他國家的相關法規

第4章 經腸營養劑的市場結構

  • 市場集中度及預測
  • SWOT分析及預測
  • 市場進入、退出及預測
  • 替代產品及預測

第5章 中國的經腸營養劑的發展

  • 市場現狀與預測
  • 需求分析及預測
  • 價格趨勢
    • 價格趨勢 (過去5年份)
    • 現在價格及分析
    • 未來價格趨勢 (今後6年份)

第6章 中國的經腸營養劑相關分析

  • 中國的經腸營養劑相關分析
  • 未來市場通訊容量
  • 目前產業發展的特徵
  • SWOT分析

第7章 進出口分析

第8章 中國的經腸營養劑的技術發展

  • 目前發展情形
  • 技術性適應性
  • 未來發展策略

第9章 中國國內的主要製造商與競爭模式

  • Netherlands Nutricia
    • 企業簡介
    • 業績
    • 市場佔有率
    • 發展策略
  • Sino-Swed Pharmaceutical Corp, Ltd. (SSPC)
  • Abbott Laboratories
  • NOVARTIS Pharmaceutical Co.,Ltd
  • Xi'an Libang Clinical Nutrition Limited Company

第10章 中國的經腸營養劑相關投資建議

  • 投資環境
  • 投資風險
  • 投資建議

第11章 今後發展預測及投資預測分析

  • 今後的產業發展趨勢
  • 工業生產預測
    • 工業總生產額 (總計4年份)
    • 銷售額收益 (總計4年份)
    • 產業總資產 (總計4年份)

第12章 來自產業專家的投資建議及見解

  • 投資機會
  • 投資風險
  • 支援治療
目錄

Market Status Quo and Forecast

Enteral nutrition preparations are the main varieties in enteral nutrition support treatment. The oral enteral nutrition emulsion and suspension include TPF,TP,TPF-T and TP-HE etc different formulas. The main manufacturers are Sino-Swed Pharmaceutical Corp, Ltd. (SSPC) and Nutricia (Wuxi), the former mainly includes such brands as: Fresubin Energy Fibre, Fresubin, Supportan and Fresubin MCT 750; while the later mainly includes Nutrison fibre, Nutrison, Peptisorb Liquid and Diason etc brands.

In China, the clinical nutrition market started in 1960s-70s. After entered into China market in 1982, China-Germany joint venture Sino-Swed Pharmaceutical is the first enterprise launching fat emulsion, amino acid and other products into market. With tens of years of development, the market is segmented increasingly, each variety increases rapidly.

In recent years, with the popularization of clinical nutrition conception in China, more and more domestic enterprises set foot in this field. According to statistics, in 2010, the market scale of enteral nutrition preparation was CNY 2.21 billion in China, by the end of 2014, it was CNY 4.11 billion and increases continually.

In overall, at present, the clinical nutrition is still in development stage in China, the home-made clinical nutrition preparations still far lag behind overseas level in respects of both quality and variety, the high-grade product market is monopolized by the imported or joint-venture products. With the constant upgrades of clinical academic concepts, from the original intravenous hyperalimentation, to equal nitrogen, equal thermal treatment, to low nitrogen, low calorie parenteral nutrition solution, to enteral nutrition and to joint nutrition treatment theory, higher requirements on convenience and safety of clinical nutrition products are put forward, especially, the emergence of infusion method of "All-in-one" nutrient solution makes the concept: parenteral nutrition should give the most reasonable infusion method, become common sense clinically.

Demand Analysis and Forecast

Statistics date suggests: in enteral nutrition products, the market ratio of standard formula is the highest, hitting 77%, the special formula accounts for 17%.

Table of Contents

1. Overview of China's Enteral Nutrition Preparation Product

  • 1.1. Definition, Property and Application Characteristics
  • 1.2. Development History

2. Enteral Nutrition Preparation in Overseas Markets

  • 2.1. Summary
  • 2.2. Overview of Asia Market
  • 2.3. Europe Market
  • 2.4. American Market

3. Environment Analysis of Enteral Nutrition Preparation

  • 3.1. Economic Development Environment in China
    • 3.1.1. GDP Change Track
    • 3.1.2. Fixed Assets Investment Change Track
    • 3.1.3. Import & Export Trade Change Track
    • 3.1.4. Macroeconomic Development Forecast
  • 3.2. Relevant Industrial Policies, Laws, Regulations and Standards
    • 3.2.1. Relevant Regulations in China
    • 3.2.2. Relevant Regulations in Foreign Countries

4. Market Characteristics of Enteral Nutrition Preparation

  • 4.1. Market Concentration Rate and Forecast
  • 4.2. SWOT Analysis and Forecast
    • 4.2.1. Strengths
    • 4.2.2. Weakness
    • 4.2.3. Opportunity
    • 4.2.4. Threats
  • 4.3. Market Entry and Exit and Forecast
  • 4.4. Substitute products and Forecast

5. Development of Enteral Nutrition Preparation in China

  • 5.1. Market Status Quo and Forecast
  • 5.2. Demand Analysis and Forecast
  • 5.3. Price Trend
    • 5.3.1. Price Trend, 2010-2014
    • 5.3.2. Current Price and Analysis
    • 5.3.3. Future Price Trend, 2015-2020

6. Analysis on Enteral Nutrition Preparation in China

  • 6.1. Analysis on Enteral Nutrition Preparation in China
  • 6.2. Future Market Capacity
  • 6.3. Current Industry Development Characteristics
  • 6.4. SWOT Analysis
    • 6.4.1. Advantageous Factors
    • 6.4.2. Disadvantageous Factors

7. of Import & Export Analysis

  • 7.1. Import Analysis
  • 7.2. Export Analysis

8. Technical Development of Enteral Nutrition Preparation in China

  • 8.1. Development Status Quo
  • 8.2. Technical Readiness
  • 8.3. Future Development Strategies

9. Key Manufacturers and Competition Pattern in China

  • 9.1. Netherlands Nutricia
    • 9.1.1. Company Profile
    • 9.1.2. Business Performance
    • 9.1.3. Market Shares
    • 9.1.4. Development Strategies
  • 9.2. Sino-Swed Pharmaceutical Corp, Ltd. (SSPC)
    • 9.2.1. Company Profile
    • 9.2.2. Business Performance
    • 9.2.3. Market Shares
    • 9.2.4. Development Strategies
  • 9.3. Abbott Laboratories
    • 9.3.1. Company Profile
    • 9.3.2. Business Performance
    • 9.3.3. Market Shares
    • 9.3.4. Development Strategies
  • 9.4. NOVARTIS Pharmaceutical Co.,Ltd
    • 9.4.1. Company Profile
    • 9.4.2. Business Performance
    • 9.4.3. Market Shares
    • 9.4.4. Development Strategies
  • 9.5. Xi'an Libang Clinical Nutrition Limited Company
    • 9.4.1. Company Profile
    • 9.4.2. Business Performance
    • 9.4.3. Market Shares
    • 9.4.4. Development Strategies

10. Investment Suggestions on Enteral Nutrition Preparation in China

  • 10.1. Investment Environment
  • 10.2. Investment Risks
  • 10.3. Investment Suggestions

11. Future Development Forecast and Investment Prospect Analysis

  • 11.1. Future Industry Development Trend
  • 11.2. Industry Operation Forecast, 2012 to 2015
    • 11.2.1. Gross Industrial Output Value, 2012 to 2015
    • 11.2.2. Sales Revenues, 2012 to 2015
    • 11.2.3. Total Industry Assets, 2012 to 2015

12. Investment Suggestions and Opinions from Industry Experts

  • 12.1. Investment Opportunity
  • 12.2. Investment Risks
  • 12.3. Countermeasures
Back to Top